Werewolf Therapeutics Inc (HOWL)

Aug 14, 2026

Werewolf Therapeutics Inc (NASDAQ: HOWL) Share Price, HOWL Stock News, HOWL Share Price & Updates - Kalkine

Aug 14, 2026

Aug 14, 2026

Werewolf Therapeutics Company Profile & Introduction - Moomoo

Aug 14, 2026

Aug 13, 2026

Werewolf Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144 - Moomoo

Aug 13, 2026

Aug 09, 2026

Price to sales forward of Werewolf Therapeutics, Inc. – NASDAQ:HOWL - TradingView

Aug 09, 2026

Aug 07, 2026

Price to book forward of Werewolf Therapeutics, Inc. – NASDAQ:HOWL - TradingView

Aug 07, 2026

Aug 03, 2026

CNSY Stock Price and Chart — NASDAQ:CNSY - TradingView

Aug 03, 2026

Jul 31, 2026

Werewolf Therapeutics (HOWL) Plunges 27.8% to $0.36 as Biotech Stock Tests Critical SupportStop Run - dars.gov.et

Jul 31, 2026

Jul 31, 2026

Werewolf Therapeutics, Inc. (HOWL) Q2 2026 Financial Results: Key Risks, Losses, and Strategic Outlook - Minichart

Jul 31, 2026

Jul 31, 2026

Werewolf Therapeutics Reports Second Quarter 2026 Financial Results and Recent Corporate Updates - GlobeNewswire

Jul 31, 2026

Jul 31, 2026

Werewolf Therapeutics Reports $21 Million Q2 Revenue - Quiver Quantitative

Jul 31, 2026

Jul 30, 2026

HOWL Q2'26 Earnings: revenue estimate is 0 USD - TradingView

Jul 30, 2026

Jul 27, 2026

Werewolf Therapeutics Inc (HOWL) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey

Jul 27, 2026

Jul 27, 2026

Werewolf Therapeutics Inc (HOWL) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey

Jul 27, 2026

Jul 27, 2026

Werewolf Therapeutics (HOWL) Stock Forum and Discussion - Moomoo

Jul 27, 2026

Jul 27, 2026

HOWL|Werewolf Therapeutics Inc|Price:0.427|Chg%:+0.067 - TradingKey

Jul 27, 2026

Jul 27, 2026

Werewolf Therapeutics Inc (HOWL) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey

Jul 27, 2026

Jul 26, 2026

TradingKey - TradingKey

Jul 26, 2026

Jul 26, 2026

Werewolf Therapeutics Inc (HOWL) Valuation: PE, PB & Fair Value Analysis - TradingKey

Jul 26, 2026

Jul 25, 2026

Werewolf Therapeutics, Inc. Revenue Breakdown – NASDAQ:HOWL - TradingView

Jul 25, 2026

Jul 24, 2026

12 Health Care Stocks Moving In Friday's Intraday Session - Benzinga

Jul 24, 2026

Jul 24, 2026

Werewolf Therapeutics Inc (HOWL) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey

Jul 24, 2026

Jul 22, 2026

HOWL stock gains on latest Wolfpack earnings context - Ad-hoc-news.de

Jul 22, 2026

Jul 20, 2026

HOWL stock trades on fresh data from Werewolf Therapeutics cancer pipeline - Ad-hoc-news.de

Jul 20, 2026

Jul 15, 2026

Werewolf Therapeutics (HOWL) Q1 2026 Earnings: Narrower Loss Surprises as Biotech Navigates Early Pipeline MilestonesLow Growth Earnings - dars.gov.et

Jul 15, 2026

Jul 12, 2026

Price to earnings forward of Werewolf Therapeutics, Inc. – NASDAQ:HOWL - TradingView

Jul 12, 2026

Jul 10, 2026

Frontier tech research, news & data - MLQ.ai

Jul 10, 2026

Jul 09, 2026

HOWL stock stays in focus as Werewolf Therapeutics pursues immuno-oncology pipeline - ad-hoc-news.de

Jul 09, 2026

Jul 08, 2026

Werewolf Therapeutics director Luke Evnin sells $44,749 in stock By Investing.com - Investing.com Nigeria

Jul 08, 2026

Jul 08, 2026

Form 4 Werewolf Therapeutics Inc For: 8 July By Investing.com - Investing.com Nigeria

Jul 08, 2026

Jul 08, 2026

Werewolf Therapeutics director Luke Evnin sells $44,749 in stock - Investing.com

Jul 08, 2026

Jul 08, 2026

Werewolf Therapeutics (HOWL) director-linked funds sell 143,199 shares - Stock Titan

Jul 08, 2026

Jul 07, 2026

Werewolf Therapeutics outlines its immuno-oncology strategy as Nasdaq-listed biotech - ad-hoc-news.de

Jul 07, 2026

Jul 06, 2026

Form 144 Werewolf Therapeutics For: 6 July By Investing.com - Investing.com Nigeria

Jul 06, 2026

Jul 06, 2026

[144] Werewolf Therapeutics, Inc. SEC Filing - Stock Titan

Jul 06, 2026

Jul 02, 2026

RA Capital trims Werewolf Therapeutics (HOWL) stake below 5% threshold - Stock Titan

Jul 02, 2026

Jul 02, 2026

Form 13D/A WEREWOLF THERAPEUTICS For: 2 July By Investing.com - Investing.com South Africa

Jul 02, 2026

Jul 02, 2026

Werewolf Therapeutics (HOWL) price target increased by 20.19% to 6.38 - MSN

Jul 02, 2026

Jul 01, 2026

Werewolf Therapeutics, Inc. Financial Disclosures & SEC Filings - TradingView

Jul 01, 2026

Jul 01, 2026

Werewolf Therapeutics Q1 2026 Earnings: Narrower-than-Expected Loss Despite Stock DeclinePre-Earnings Setup - dars.gov.et

Jul 01, 2026

Jun 30, 2026

Werewolf Therapeutics director Luke Evnin sells $47,125 in stock By Investing.com - Investing.com Australia

Jun 30, 2026

Jun 29, 2026

Form 4 Werewolf Therapeutics Inc For: 29 June By Investing.com - Investing.com South Africa

Jun 29, 2026

Jun 29, 2026

Form 144 Werewolf Therapeutics For: 29 June By Investing.com - Investing.com South Africa

Jun 29, 2026

Jun 29, 2026

Werewolf Therapeutics director Luke Evnin sells $47,125 in stock - Investing.com

Jun 29, 2026

Jun 29, 2026

Entities tied to Werewolf Therapeutics (HOWL) director Luke Evnin sell 157K shares - Stock Titan

Jun 29, 2026

Jun 27, 2026

Werewolf Therapeutics, Inc. Actuals & Estimates (NASDAQ:HOWL) - TradingView

Jun 27, 2026

Jun 27, 2026

Form 13D/A WEREWOLF THERAPEUTICS For: 26 June By Investing.com - Investing.com South Africa

Jun 27, 2026

Jun 27, 2026

Werewolf Therapeutics Inc (HOWL) Financial Health: Profitability & Balance Sheet Analysis - TradingKey

Jun 27, 2026

Jun 26, 2026

RA Capital reports 6% Werewolf Therapeutics (HOWL) stake after June share sales - Stock Titan

Jun 26, 2026